Scientists adopt trust signals first. The technology comes second.
I surveyed 213 life sciences professionals for my MBA dissertation. The strongest predictor of ML adoption wasn't capability. It was trust.
Read →
Bioicus LAB
Innovation stalls in the gaps between teams. Connected, it ships as a system or a launch.
For life science organisations ready to launch or scaling up.
Ready to move forward? →
Launches and systems, built with scientific rigour and commercial intent.
The science is ready, but R&D, marketing and sales are not moving together. Roadmap, go-to-market and launch plan, executed alongside your team until the product ships. Trusted by a Cambridge-based deep biotech: from stalled to launched in 12 weeks.
Read how I think →As teams grow, documents, quality and commercial processes stop working ad hoc. DMS/QMS and workflows built on the tools you already have, owned by your team when the project closes.
See the cases →BioRhythm. 12 weeks, part-time, embedded in your team. One system deployed or one product launched. Then your team owns it.
See BioRhythm →
I surveyed 213 life sciences professionals for my MBA dissertation. The strongest predictor of ML adoption wasn't capability. It was trust.
Read →
Biology calls it obligate mutualism. Business calls it your best client. Both can end you.
Read →
Having a great scientific idea that doesn't stick with the market? The problem is rarely in the lab.
Read →Founder
Projects closed. Frameworks deployed. Products launched.
Serving life science companies across EMEA and LATAM markets.
My Bio →